Literature DB >> 17259662

PPARs and Bone Metabolism.

Beata Lecka-Czernik1.   

Abstract

Entities:  

Year:  2006        PMID: 17259662      PMCID: PMC1679960          DOI: 10.1155/PPAR/2006/18089

Source DB:  PubMed          Journal:  PPAR Res            Impact factor:   4.964


× No keyword cloud information.
Welcome to the inaugural special issue of PPAR Research: PPARs and Bone Metabolism. In addition to the key roles PPARs play in numerous processes including glucose and fat metabolism, inflammation, cancer, and central nervous system maintenance, a new role for PPAR-γ has recently emerged: the maintenance of bone homeostasis during aging and disease. In this premier issue we have assembled what is close to a comprehensive overview of the role of PPAR-γ in the control of bone maintenance. This takes into account PPAR-γ's role in mesenchymal stem cell lineage allocation, possible cross-talk with relevant nuclear receptors, examination of PPAR-γ gene polymorphisms and bone mineral density in humans, a role of PPAR-γ in bone loss due to skeletal disuse, evidence that human bone is vulnerable to antidiabetic therapies with PPAR-γ agonists, the thiazolidinediones, and evidence that the antiosteoblastic activity of PPAR-γ can be separated from its proadipocytic and antidiabetic activities by using selective modulators. We also present a novel hypothesis that PPAR-γ acts as a regulator of chondrocyte development and cartilage homeostasis. We realize that we have not covered all aspects of PPARs involvement in the control of bone maintenance; however, this introduction should serve as a competent first attempt to present these new aspects of bone biology to the broader audience of our readers.
  4 in total

1.  Aging and bone loss: new insights for the clinician.

Authors:  Oddom Demontiero; Christopher Vidal; Gustavo Duque
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-04       Impact factor: 5.346

2.  S100A16 inhibits osteogenesis but stimulates adipogenesis.

Authors:  Dong Li; Rihua Zhang; Weidong Zhu; Yi Xue; Yuanyuan Zhang; Qiong Huang; Menglan Liu; Yun Liu
Journal:  Mol Biol Rep       Date:  2013-03-25       Impact factor: 2.316

3.  Peptidomimetic inhibitor of L-plastin reduces osteoclastic bone resorption in aging female mice.

Authors:  Hanan Aljohani; Joseph P Stains; Sunipa Majumdar; Deepa Srinivasan; Linda Senbanjo; Meenakshi A Chellaiah
Journal:  Bone Res       Date:  2021-04-09       Impact factor: 13.567

4.  Peroxisome proliferator-activated receptors: "key" regulators of neuroinflammation after traumatic brain injury.

Authors:  Philip F Stahel; Wade R Smith; Jay Bruchis; Craig H Rabb
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.